Anna I. Kakafika

3.2k total citations
57 papers, 2.3k citations indexed

About

Anna I. Kakafika is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Anna I. Kakafika has authored 57 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 25 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Epidemiology. Recurrent topics in Anna I. Kakafika's work include Lipoproteins and Cardiovascular Health (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Liver Disease Diagnosis and Treatment (9 papers). Anna I. Kakafika is often cited by papers focused on Lipoproteins and Cardiovascular Health (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Liver Disease Diagnosis and Treatment (9 papers). Anna I. Kakafika collaborates with scholars based in Greece, United Kingdom and Norway. Anna I. Kakafika's co-authors include Vasilios G. Athyros, Asterios Karagiannis, Κωνσταντίνος Τζιόμαλος, Moses Elisaf, Dimitri P. Mikhailidis, Dimitri P. Mikhailidis, Evangelos Liberopoulos, Athanasios A. Papageorgiou, Emmanuel S. Ganotakis and Eleni Bairaktari and has published in prestigious journals such as The American Journal of Cardiology, Journal of Lipid Research and American Heart Journal.

In The Last Decade

Anna I. Kakafika

55 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna I. Kakafika Greece	28	1.0k	858	594	496	325	57	2.3k
Emmanuel S. Ganotakis Greece	36	819 0.8×	969 1.1×	640 1.1×	586 1.2×	258 0.8×	97	3.2k
Athanasios A. Papageorgiou Greece	26	1.5k 1.5×	1.1k 1.3×	406 0.7×	814 1.6×	330 1.0×	46	2.7k
Genshi Egusa Japan	27	973 1.0×	1.0k 1.2×	465 0.8×	862 1.7×	219 0.7×	75	2.7k
Günther Silbernagel Austria	30	1.0k 1.0×	804 0.9×	404 0.7×	563 1.1×	389 1.2×	95	2.7k
Dov Gavish Israel	26	1.1k 1.1×	787 0.9×	380 0.6×	714 1.4×	203 0.6×	70	2.7k
Vasilis Tsimihodimos Greece	31	1.4k 1.3×	1.6k 1.9×	525 0.9×	524 1.1×	296 0.9×	113	3.3k
Tanja B. Grammer Germany	36	936 0.9×	845 1.0×	456 0.8×	906 1.8×	684 2.1×	110	3.7k
Davide Noto Italy	30	1.2k 1.2×	947 1.1×	539 0.9×	839 1.7×	97 0.3×	135	2.9k
Tohru Funahashi Japan	17	411 0.4×	420 0.5×	842 1.4×	458 0.9×	277 0.9×	47	1.8k
Miguel Ángel Hernández-Presa Spain	16	802 0.8×	337 0.4×	329 0.6×	713 1.4×	155 0.5×	26	2.4k

Countries citing papers authored by Anna I. Kakafika

Since Specialization

Citations

This map shows the geographic impact of Anna I. Kakafika's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna I. Kakafika with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna I. Kakafika more than expected).

Fields of papers citing papers by Anna I. Kakafika

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna I. Kakafika. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna I. Kakafika. The network helps show where Anna I. Kakafika may publish in the future.

Co-authorship network of co-authors of Anna I. Kakafika

This figure shows the co-authorship network connecting the top 25 collaborators of Anna I. Kakafika. A scholar is included among the top collaborators of Anna I. Kakafika based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna I. Kakafika. Anna I. Kakafika is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Athyros, Vasilios G., Apostolos Hatzitolios, Asterios Karagiannis, et al.. (2011). IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Archives of Medical Science. 6(6). 984–992. 36 indexed citations

Vassiliadis, Themistoklis, Sofia Vakalopoulou, Όλγα Γιουλεμέ, et al.. (2010). Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survival. Hepatology Research. 40(2). 161–170. 28 indexed citations

Athyros, Vasilios G., Anna I. Kakafika, Athanasios A. Papageorgiou, et al.. (2009). Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors. Nutrition Metabolism and Cardiovascular Diseases. 21(3). 213–221. 66 indexed citations

Athyros, Vasilios G., Anna I. Kakafika, Athanasios A. Papageorgiou, et al.. (2008). Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study. Current Medical Research and Opinion. 24(6). 1593–1599. 12 indexed citations

Athyros, Vasilios G., Anna I. Kakafika, Anthony S. Wierzbicki, Asterios Karagiannis, & D. P. Mikhailidis. (2008). Targeting triglycerides in secondary prevention: should we bother?. International Journal of Clinical Practice. 63(1). 15–18. 4 indexed citations

Karagiannis, Asterios, Κωνσταντίνος Τζιόμαλος, Anna I. Kakafika, et al.. (2008). Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas. Endocrine Related Cancer. 15(3). 693–700. 17 indexed citations

Athyros, Vasilios G., Anna I. Kakafika, Athanasios A. Papageorgiou, et al.. (2007). Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients. The Open Cardiovascular Medicine Journal. 1(1). 8–14. 2 indexed citations

Paraskevas, Kosmas I., et al.. (2007). Statins Exert Multiple Beneficial Effects on Patients Undergoing Percutaneous Revascularization Procedures. Current Drug Targets. 8(8). 942–951. 35 indexed citations

Athyros, Vasilios G., Anna I. Kakafika, Athanasios A. Papageorgiou, et al.. (2007). Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients§. The Open Cardiovascular Medicine Journal. 1(1). 8–14. 23 indexed citations

10.

Jagroop, I.A., Anna I. Kakafika, & D.P. Mikhailidis. (2007). Platelets and Vascular Risk: An Option for Treatment. Current Pharmaceutical Design. 13(16). 1669–1683. 16 indexed citations

11.

Karagiannis, Asterios, Dimitri P. Mikhailidis, Vasilios G. Athyros, et al.. (2007). The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?. Expert Opinion on Therapeutic Targets. 11(2). 191–205. 23 indexed citations

12.

Athyros, Vasilios G., et al.. (2007). Effectiveness of Ezetimibe Alone or in Combination With Twice a Week Atorvastatin (10 mg) for Statin Intolerant High-Risk Patients. The American Journal of Cardiology. 101(4). 483–485. 57 indexed citations

13.

Liberopoulos, Evangelos, Anna I. Kakafika, George Miltiadous, et al.. (2007). Effect of Paraoxonase 1 Polymorphisms on the Response of Lipids and Lipoprotein-associated Enzymes to Treatment with Fluvastatin. Archives of Medical Research. 38(4). 403–410. 13 indexed citations

14.

Athyros, Vasilios G., Emmanuel S. Ganotakis, Ioannis Goudevenos, et al.. (2006). Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study.. PubMed. 46(6). 380–6. 47 indexed citations

15.

Liberopoulos, Evangelos, Anna I. Kakafika, George Miltiadous, et al.. (2006). The Effect of Apolipoprotein E Polymorphism on the Response to Lipid-Lowering Treatment With Atorvastatin or Fenofibrate. Journal of Cardiovascular Pharmacology and Therapeutics. 11(3). 211–221. 34 indexed citations

16.

Kakafika, Anna I., Vasileios Papadopoulos, Konstantinos Mimidis, & Dimitri P. Mikhailidis. (2006). Coagulation, Platelets, and Acute Pancreatitis. Pancreas. 34(1). 15–20. 51 indexed citations

17.

Milionis, Haralampos J., Anna I. Kakafika, Sofia Tsouli, et al.. (2004). Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. American Heart Journal. 148(4). 635–640. 120 indexed citations

18.

Bairaktari, Eleni, et al.. (2003). Hypouricemia in individuals admitted to an inpatient hospital-based facility. American Journal of Kidney Diseases. 41(6). 1225–1232. 20 indexed citations

19.

Kakafika, Anna I., Vasilis Tsimihodimos, Afroditi P. Tambaki, et al.. (2003). The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity. Journal of Lipid Research. 44(10). 1919–1926. 22 indexed citations

20.

Liamis, Georgé, Anna I. Kakafika, Eleni Bairaktari, et al.. (2002). Combined Treatment with Fibrates and Small Doses of Atorvastatin in Patients with Mixed Hyperlipidemia. Current Medical Research and Opinion. 18(3). 125–128. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact